← Back to catalogue
Published

ligustrazine

vr.tr.ligustrazine · thing-q11319317

Enable an agent to identify ligustrazine, assess the form and quality of a material containing it, and determine which handling or use decisions the available evidence supports.

Thing Registry Physical world and living systems PHY.MAT

Bundle → Layer → Finding → Questions Filled

6 bundles · 11 layers · 18 findings · 36 questions

Ligustrazine identity and forms Establish which records and materials denote the parent compound and which denote related forms.

Parent structure and identifiers

Resolve the registry entry to a chemically explicit identity.

Identity concordance

Require agreement between the ligustrazine name, tetramethylpyrazine structure and external identifiers.

  1. Does the candidate material match 2,3,5,6-tetramethylpyrazine rather than a different compound abbreviated TMP? definition
  2. Which authoritative records establish its CAS, PubChem CID and EC number, and do their structures agree? provenance

Salt and mixture boundaries

Distinguish the parent moiety from counterion-bearing materials and mixtures.

Form-resolved material

Record form relationships without creating an unsupported registry split.

  1. Is the material the free base, a specified hydrochloride or phosphate salt, another form, or a mixture? boundary
  2. What counterion stoichiometry, hydration or solvation evidence determines its formula and mass basis? measurement
  3. Does a linked registry model already own this form or containing product? boundary
Ligustrazine batch quality Establish what a particular batch contains and how confidently that composition is known.

Identity and assay

Tie identity confirmation and quantitative content to suitable analytical evidence.

Analytical confirmation

Assess whether identity and content are demonstrated rather than inferred from a supplier label.

  1. Which reference standard and analytical results confirm ligustrazine identity in this matrix? provenance
  2. Does the reported assay measure mass content, chromatographic area, salt content or free-base equivalents? measurement
  3. What uncertainty and method limitations affect acceptance of the reported content? measurement

Impurities and grade

Connect route-specific contaminants and batch documentation to intended use.

Grade-supported acceptance

Judge a batch against an explicit specification rather than treating all ligustrazine grades as equivalent.

  1. Which related pyrazines, residual solvents, water and other route-relevant impurities were measured? measurement
  2. What lot-specific records support the claimed synthetic, extracted or fermentation-derived provenance? provenance
  3. Which documented acceptance limits make this batch suitable for the proposed analytical, research, food or pharmaceutical use? action
Ligustrazine physical state and preparation Describe the form-dependent properties needed to inspect and prepare ligustrazine materials.

Solid and thermal properties

Evaluate phase observations and thermal measurements for the identified material.

Conditioned physical constants

Attach each physical constant to its tested form, purity and measurement conditions.

  1. What phase and melting range are supported for the identified ligustrazine form at the recorded purity? measurement
  2. Which boiling-point or decomposition measurements are available, and at what pressure and method conditions? measurement

Dissolution and equivalent content

Support solution preparation without transferring properties or mass conversions across unspecified forms.

Supported solution preparation

Determine whether an intended ligustrazine concentration can be prepared and meaningfully reported.

  1. What measured solubility supports the target concentration in the chosen solvent at the intended pH and temperature? measurement
  2. What stoichiometry, water content and assay corrections are needed to express this preparation as ligustrazine free-base equivalents? measurement
  3. What evidence indicates precipitation or concentration change after dilution or a change in pH? action
Ligustrazine stability and handling Connect storage history and safety evidence to the current material.

Storage and retest

Assess stability separately for the supplied solid and prepared solutions.

Retained material fitness

Determine whether storage evidence supports continued use of the ligustrazine batch or preparation.

  1. Which stability studies support temperature, light, moisture and container conditions for this exact form? provenance
  2. What assay, impurity or appearance changes define failure after storage or solution preparation? measurement
  3. What retest or quarantine decision follows the recorded excursion and elapsed storage time? action

Form-specific hazards

Resolve handling requirements against the actual substance or mixture being used.

Applicable safety evidence

Keep ligustrazine hazard evidence distinct from hazards contributed by solvents, counterions or formulation ingredients.

  1. Which current SDS and GHS classification apply to the identified form, concentration and jurisdiction? provenance
  2. Is a substance-specific occupational exposure limit established, or is that information absent? definition
  3. What handling, spill and disposal measures follow from the applicable evidence for the planned operation? action
Ligustrazine activity and use evidence Bound biological and use claims by their evidence, tested material and governing context.

Biological claim boundaries

Represent activity claims without equating experimental effects with established clinical benefit.

Exposure-linked activity

Associate each proposed effect with the tested ligustrazine form, exposure and study design.

  1. For a claimed platelet, vascular or neuroprotective effect, what primary study identifies the tested form and measured endpoint? provenance
  2. What concentration or exposure produced the result, and how were vehicle effects, impurities and toxicity assessed? measurement
  3. Does the evidence concern a biochemical assay, cells, animals or humans, and what inference remains unsupported? boundary

Use and jurisdiction

Link a proposed use to applicable records without interpreting chemical registration as blanket authorization.

Use-specific eligibility

Determine which authority and specification govern the proposed ligustrazine use.

  1. What current official record governs this form's intended medicinal, flavouring or research use in the relevant jurisdiction? provenance
  2. Does that record apply to the parent substance, a particular salt, a grade or a finished product? boundary
  3. What additional material documentation is required before the proposed use can proceed? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of ligustrazine this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these kinds and varieties hold for the sense of ligustrazine this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these identifiers and schemes hold for the sense of ligustrazine this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of ligustrazine this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these typical measurements hold for the sense of ligustrazine this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of ligustrazine this model covers, and on what evidence? provenance

Regional variation

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these regional variation hold for the sense of ligustrazine this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of ligustrazine this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Physical world and living systems
Entry kind
thing
Plane
PHY
Domain
PHY.MAT

What it is Filled

Ligustrazine, or 2,3,5,6-tetramethylpyrazine, is an aromatic nitrogen heterocycle with molecular formula C8H12N2, associated with the medicinal plant Ligusticum chuanxiong and also encountered as an aroma compound.

In scope

  • Parent-compound identity, synonyms and authoritative chemical identifiers
  • Relationships to salt forms, hydrates and dissolved species
  • Batch composition, assay basis, impurities and grade
  • Physical properties, solubility and stability under recorded conditions
  • Evidence supporting biological activity, handling requirements and use eligibility

Out of scope

  • Botanical identity, cultivation and whole-extract composition of source plants
  • Complete manufacturing or extraction process models
  • Finished medicine formulations, packaging and administration devices
  • Patient-specific treatment, dosing and clinical decisions
  • Food formulations and sensory properties of complete foods

Why it exists Filled

Enable an agent to identify ligustrazine, assess the form and quality of a material containing it, and determine which handling or use decisions the available evidence supports.

Distinguishing features Filled

  • Ligustrazine denotes 2,3,5,6-tetramethylpyrazine: a pyrazine ring with methyl substituents at all four carbon positions; matching only the abbreviation TMP is insufficient. [PubChem identity record](https://pubchem.ncbi.nlm.nih.gov/compound/tetramethylpyrazine)
  • The parent compound has molecular formula C8H12N2, molecular weight 136.19 g/mol, CAS 1124-11-4 and PubChem CID 14296; a candidate record should agree across structure and identifiers. [PubChem identity record](https://pubchem.ncbi.nlm.nih.gov/compound/tetramethylpyrazine)
  • Ligustrazine hydrochloride requires a counterion-aware identity and must not inherit the parent's formula or mass basis unchanged. [PubChem hydrochloride record](https://pubchem.ncbi.nlm.nih.gov/compound/156709)
  • A plant extract, food or formulation containing ligustrazine is not equivalent to an isolated ligustrazine batch; recognition requires composition and analytical evidence.

What robots and AI may and may not do Filled

Must not

  • Recommend ligustrazine or herbal products containing it as a treatment for a person's condition.
  • Present traditional medicine claims about it as established clinical evidence.
  • Label an unanalysed plant extract as pure ligustrazine.
  • Help supply it as a medicine where it is not authorized for that use.

Only with a human decision

  • Using ligustrazine in a food, supplement or medicine intended for people.
  • Disposing of bulk quantities in a laboratory.

May

  • Identify ligustrazine from analytical data and report the grade and source of a sample.
  • Describe its documented uses as a flavour compound and in traditional medicine, citing sources.

Moral aspects Filled

  • Traditional medicine claims can mislead patients into delaying effective treatment.
  • Respect for the medical traditions that use it should not replace evidence about safety.

Who is affected

  • Patients and consumers
  • Laboratory workers
  • Practitioners of traditional medicine

Owners Filled

Steward

The laboratory or business that holds the material; medicines regulators decide on any therapeutic use.

Links to other meta-models Filled

parent

  • Q109367198 - registry parent class
  • Q109393859 - registry parent class
  • Q3894391 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.ligustrazine
  • Wikidata: Q11319317 (https://www.wikidata.org/wiki/Q11319317)

Direct properties required Filled

  • Chemical identity: Structure-resolved name, CAS, PubChem CID, verified EC number and identifier source
  • Material form: Free base, specified salt, hydrate or solvate, solution, mixture, unresolved
  • Ligustrazine content: % mass fraction, mg/g or mol/L; state as-is, dry, salt or free-base-equivalent basis
  • Impurity profile: Individual impurities, residual solvents and water in mg/kg or % mass fraction, with method and detection limits
  • Phase and thermal behavior: Observed phase; melting range and boiling or decomposition behavior in °C with pressure, form and method
  • Solubility and solution conditions: g/L or mol/L with solvent, temperature, pH and material form
  • Batch provenance and grade: Supplier, lot, production-route record, certificate of analysis and documented grade specification
  • Storage fitness: Within supported conditions, excursion pending assessment, retest required, rejected, unknown
  • Biological evidence context: Study, tested form, concentration or exposure, experimental system, endpoint and evidence level
  • Safety and use status: Applicable SDS, GHS classification, exposure-limit source and jurisdiction-specific use record with date

Recognition required Filled

  • A white crystalline solid with a nutty or roasted odour, which does not settle identity on its own.
  • Identity is settled by spectroscopy, chromatography or melting point against a reference.

Capabilities and actions required Filled

  • Resolve a ligustrazine label against structure and identifiers, flagging ambiguous abbreviations or salt records.
  • Compare a batch's identity, assay and impurity results with the specification for its intended use.
  • Convert a specified salt quantity to free-base equivalents when stoichiometry, hydration and assay basis are known.
  • Assess whether a proposed solvent and concentration have supporting solubility and stability evidence.
  • Determine whether storage excursions require retesting, quarantine or rejection.
  • Retrieve evidence relevant to an intended research or commercial use while retaining its material-form and jurisdiction limits.

Hazards and failure modes required Filled

  • Unsupervised medicinal use can interact with blood-thinning or other medicines.
  • Misidentified or contaminated extracts can expose consumers to unknown substances.

Standards and interfaces required Filled

  • Globally Harmonized System of Classification and Labelling of Chemicals (GHS), United Nations.

Context of use required Filled

  • Ligustrazine is encountered in chemical research, medicinal plant analysis and studies of aroma compounds in foods.
  • Analytical laboratories use it as a target compound or reference material when investigating composition and identity.
  • Pharmacological research examines its biological activity, with interpretation depending on the chemical form, purity and study context.

Sources Filled

  1. Wikidata item Q11319317: ligustrazine - identity and sense of the item
  2. Wikipedia: Tetramethylpyrazine - general description of the item

Open questions

  • Which existing Vercy models, if any, already own tetramethylpyrazine or its salt forms, and how should this entry link to them without duplicating ownership?
  • What verified EC identifier, jurisdiction-specific GHS classifications and occupational exposure limits apply to the parent compound and relevant supplied forms?
  • Which primary measurements establish form-specific melting, boiling or decomposition behavior, aqueous solubility and pH dependence?
  • Which validated specifications distinguish acceptable ligustrazine grades, including route-dependent impurities and free-base-equivalent assay conventions?
  • Which current official use records and primary human studies support medicinal or flavouring claims, and which claims remain experimental?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q11319317/spec.json